Product Program year 2020 Source: CMS Open Payments

EMBOTRAP II Revascularization Device

Device Neurovascular

Open in the dashboard

General payments

$584,717

1,910 payments

Research payments

$4,719,865

319 payments

Through program year 2020, $584,717 in general payments and $4,719,865 in research payments were reported against EMBOTRAP II Revascularization Device (Neurovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $285,564 958
2020 Research $2,017,832 223
2019 General $299,153 952
2019 Research $2,702,033 96

Breakdown

Who paid General payments · program years 2019–2020
  1. Medical Device Business Services, Inc. $514,541 301 payments
  2. DePuy Synthes Sales Inc. $67,867 1,585 payments
  3. Biosense Webster, Inc. $2,148 23 payments
  4. DePuy Synthes Products, Inc. $161 1 payment
Top recipients General payments · program year 2020
  1. Osama Zaidat Vascular Neurology · Toledo, OH $54,104 19% · 14 payments
  2. Wayne Olan Neuroradiology · Washington, DC $30,001 11% · 10 payments
  3. Adnan Siddiqui Neurological Surgery · Williamsville, NY $26,775 9% · 6 payments
  4. Jogi Pattisapu Neurological Surgery · Orlando, FL $14,400 5% · 1 payment
  5. David Liebeskind Neurology · Los Angeles, CA $13,950 5% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Neurological Surgery $92,888 33% · 113 practitioners
  2. Vascular Neurology Psychiatry & Neurology $77,080 27% · 24 practitioners
  3. Neuroradiology Radiology $51,584 18% · 41 practitioners
  4. Neurology Psychiatry & Neurology $26,196 9% · 33 practitioners
  5. Vascular & Interventional Radiology Radiology $19,552 7% · 63 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $58,791 21% · 10 recipients
  2. New York $44,067 15% · 21 recipients
  3. California $34,706 12% · 62 recipients
  4. District of Columbia $30,113 11% · 3 recipients
  5. Tennessee $24,443 9% · 14 recipients

The top 5 of 36 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,910 general · 319 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record